128 related articles for article (PubMed ID: 23513423)
1. [Long term survival patient on hemodialysis--case report].
Orlić L; Sladoje-Martinović B; Cosić SZ; Maleta I; Vuksanović-Mikulicić S; Bubić I; Pavletić-Persić M; Racki S
Acta Med Croatica; 2012 Oct; 66 Suppl 2():81-4. PubMed ID: 23513423
[TBL] [Abstract][Full Text] [Related]
2. Appendix to dialysis centre guidelines: recommendations for the relationship between outpatient haemodialysis centres and reference hospitals. Opinions from the Outpatient Dialysis Group. Grupo de Trabajo de Hemodiálisis Extrahospitalaria.
Berdud I; Arenas MD; Bernat A; Ramos R; Blanco A;
Nefrologia; 2011; 31(6):664-9. PubMed ID: 22130281
[TBL] [Abstract][Full Text] [Related]
3. [Analysis of the survival of permanent vascular access ports].
Rodríguez JA; Ferrer E; Olmos A; Codina S; Borrellas J; Piera L
Nefrologia; 2001; 21(3):260-73. PubMed ID: 11471307
[TBL] [Abstract][Full Text] [Related]
4. [Renal replacement therapy by hemodialysis: an overview].
Jacobs C
Nephrol Ther; 2009 Jul; 5(4):306-12. PubMed ID: 19481513
[TBL] [Abstract][Full Text] [Related]
5. Peritoneal dialysis is the therapy of choice for end-stage renal disease patients with hereditary clotting disorders.
Bajo MA; del Peso G; Jiménez V; Aguilera A; Villar A; Jiménez C; Selgas R
Adv Perit Dial; 2000; 16():170-3. PubMed ID: 11045286
[TBL] [Abstract][Full Text] [Related]
6. Slovenian Renal Replacement Therapy Registry: excerpts from the 2008 Annual Report.
Buturović-Ponikvar J; Gubenšek J; Arnol M
Ther Apher Dial; 2011 Jun; 15(3):228-33. PubMed ID: 21624067
[TBL] [Abstract][Full Text] [Related]
7. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
8. Survival on renal replacement therapy: data from the EDTA Registry.
Brunner FP; Fassbinder W; Broyer M; Oulès R; Brynger H; Rizzoni G; Challah S; Selwood NH; Dykes SR; Wing AJ
Nephrol Dial Transplant; 1988; 3(2):109-22. PubMed ID: 3140077
[TBL] [Abstract][Full Text] [Related]
9. [Renal Epidemiology and Information Network: 2007 annual report ].
Couchoud C; Lassalle M; Stengel B; Jacquelinet C
Nephrol Ther; 2009 Jun; 5 Suppl 1():S3-144. PubMed ID: 19524212
[TBL] [Abstract][Full Text] [Related]
10. [The past, the present and the future of renal replacement therapy].
Tesar V
Vnitr Lek; 2011; 57(7-8):603-6. PubMed ID: 21877592
[TBL] [Abstract][Full Text] [Related]
11. [25 years of dialysis and kidney transplantation in children and adolescents].
Gämperli A; Leumann E; Neuhaus TJ; Schlumpf R; Largiadèr F
Schweiz Med Wochenschr; 1996 Jan; 126(3):77-85. PubMed ID: 8578289
[TBL] [Abstract][Full Text] [Related]
12. [Renal graft survival in patients with systemic lupus erythematosus].
Chew-Wong A; Soltero L; Diná E; Alvarez-Sandoval E; Alberú J; Gamba G; Correa-Rotter R
Rev Invest Clin; 2002; 54(1):21-8. PubMed ID: 11995403
[TBL] [Abstract][Full Text] [Related]
13. Dialysis after kidney transplant failure: do patients start in a worse condition than the general population with chronic kidney disease?
Caldés Ruisánchez S; Marcén Letosa R; Amezquita Orjuela Y; Fernández Lucas M; Rivera Gorrin M; Galeano Álvarez C; Fernández Rodríguez A; Teruel Briones JL; Quereda Rodríguez-Navarro C
Nefrologia; 2011; 31(1):51-7. PubMed ID: 21270913
[TBL] [Abstract][Full Text] [Related]
14. Renal graft outcome in simultaneous kidney transplantation combined with other organs: experience of a single center.
Gutierrez-Baños J; Portillo J; Ballestero R; Zubillaga S; Ramos E; Campos J; Hidalgo E
Transplant Proc; 2008 Dec; 40(10):3424-7. PubMed ID: 19100404
[TBL] [Abstract][Full Text] [Related]
15. Chronic haemodialysis with PTFE arterio-venous grafts.
Chia KH; Ong HS; Teoh MK; Lim TT; Tan SG
Singapore Med J; 1999 Nov; 40(11):685-90. PubMed ID: 10709405
[TBL] [Abstract][Full Text] [Related]
16. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant.
Wolfe RA; Ashby VB; Milford EL; Ojo AO; Ettenger RE; Agodoa LY; Held PJ; Port FK
N Engl J Med; 1999 Dec; 341(23):1725-30. PubMed ID: 10580071
[TBL] [Abstract][Full Text] [Related]
17. Duration of end-stage renal disease and kidney transplant outcome.
Goldfarb-Rumyantzev A; Hurdle JF; Scandling J; Wang Z; Baird B; Barenbaum L; Cheung AK
Nephrol Dial Transplant; 2005 Jan; 20(1):167-75. PubMed ID: 15546892
[TBL] [Abstract][Full Text] [Related]
18. Efficiency of the kidney disease outcomes quality initiative guidelines for preemptive vascular access in an academic setting.
Kimball TA; Barz K; Dimond KR; Edwards JM; Nehler MR
J Vasc Surg; 2011 Sep; 54(3):760-5; discussion 765-6. PubMed ID: 21703804
[TBL] [Abstract][Full Text] [Related]
19. [20 years' experience in the treatment of children with terminal renal insufficiency in Yugoslavia].
Peco-Antić A; Popović-Rolović M; Jovanović O; Marsenić O; Babić D; Kostić M; Kruscić O; Culić D; Trajković D
Srp Arh Celok Lek; 2000; 128(11-12):363-9. PubMed ID: 11337914
[TBL] [Abstract][Full Text] [Related]
20. [Incidence of chronic renal failure during 35 years at the Rijeka Clinical Hospital Center].
Orlić L; Matić-Glazar D; Vlahović A; Zivcić-Cosić S; Maleta I; Martinović BS; Racki S; Madzar Z
Acta Med Croatica; 2004; 58(1):73-7. PubMed ID: 15125398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
